Abstract
We examined Massachusetts tuberculosis surveillance data from to 2009 to 2018. Of 1533 culture-confirmed cases, 190 (12.4%) demonstrated resistance to isoniazid including 32 (2.1%) with rifampin resistance. In multivariable analysis, isoniazid resistance increased significantly over time (per-year odds ratio = 1.07, 95% confidence interval = 1.01–1.13, P = .018) and was associated with younger age, foreign birth, and prior tuberculosis treatment.
Funding Information
  • National Institutes of Health (T32 AI052074)
  • National Institute of Allergy and Infectious Diseases (R01 AI119037)
  • Boston University Clinical HIV/AIDS Research Training Program
  • Providence/Boston Center for AIDS Research (P30 AI042853)
  • Boston University/Rutgers Tuberculosis Research Unit (U19 AI111276)
  • US-India Vaccine Action Program Initiative on Tuberculosis

This publication has 13 references indexed in Scilit: